Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1989 Jan;65(1):14–17. doi: 10.1136/sti.65.1.14

Treating genitourinary and pharyngeal gonorrhoea with single dose ceftriaxone.

J Christophersen 1, A C Bollerup 1, E From 1, J O Rønne-Rasmussen 1, K Quitzau 1
PMCID: PMC1196180  PMID: 2921047

Abstract

The efficacy of ceftriaxone 250 mg given as a single intramuscular dose to treat genitourinary and pharyngeal gonorrhoea is compared with the outcome of the Danish standard treatment for uncomplicated genitourinary gonorrhoea, pivampicillin 1.4 g and probenecid 1 g, both given by mouth. The study comprised 327 patients for whom the diagnosis of gonorrhoea was made by microscopy of a methylene blue stained smear at their first visit to the clinic and for whom the diagnosis was later confirmed by culture of Neisseria gonorrhoeae. One hundred and seventy patients with genitourinary gonorrhoea (18 with and 152 without concomitant pharyngeal infection) were treated with ceftriaxone. One hundred and fifty seven (17 with and 140 without concomitant pharyngeal infection) were treated with pivampicillin. One week after treatment N gonorrhoeae was isolated from none of 18, 1/152, (1%), 11/17 (65%), and 6/140 (4%) patients, respectively. At a second attendance two weeks after treatment no further treatment failure was found. During the study period, a further 52 patients with pharyngeal infection (with or without concomitant genitourinary infection) that was shown by culture only were treated with a single intramuscular injection of 250 mg ceftriaxone. No treatment failure was observed in this group. Only minor adverse drug reactions were seen. Ceftriaxone 250 mg as a single intramuscular injection is therefore safe and effective in treating gonorrhoea, including pharyngeal infection.

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bro-Jorgensen A., Jensen T. Gonococcal pharyngeal infections. Report of 110 cases. Br J Vener Dis. 1973 Dec;49(6):491–499. doi: 10.1136/sti.49.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dixon C. A., Bittiner J. B., Shahidullah M., Slack R. C., Sulaiman M. Z. Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women. Genitourin Med. 1986 Apr;62(2):78–81. doi: 10.1136/sti.62.2.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Graudal C., Bollerup A. C., Lange K., Seier K., Lind I. The outcome of single-dose cefuroxime treatment in patients with pharyngeal gonorrhea. Sex Transm Dis. 1985 Jan-Mar;12(1):49–51. doi: 10.1097/00007435-198501000-00010. [DOI] [PubMed] [Google Scholar]
  4. Hagdrup H., Serup J. Pivampicillin-engangsbehandling af gonoré og behandlingssvigt. Ugeskr Laeger. 1985 May 6;147(19):1536–1537. [PubMed] [Google Scholar]
  5. Hagdrup H., Serup J. Tonsillaer og rektal gonoré. Nyttevirkning af rutinemaessig dyrkning for gonokokker fra tonsiller og rectum. Ugeskr Laeger. 1985 Nov 4;147(45):3607–3609. [PubMed] [Google Scholar]
  6. Handsfield H. H., Murphy V. L. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men. Lancet. 1983 Jul 9;2(8341):67–70. doi: 10.1016/s0140-6736(83)90058-2. [DOI] [PubMed] [Google Scholar]
  7. Handsfield H. H., Murphy V. L. Treatment of uncomplicated gonorrhea in women with single-dose cefonicid. Sex Transm Dis. 1985 Apr-Jun;12(2):90–92. doi: 10.1097/00007435-198504000-00008. [DOI] [PubMed] [Google Scholar]
  8. Judson F. N., Ehret J. M., Handsfield H. H. Comparative study of ceftriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhea. JAMA. 1985 Mar 8;253(10):1417–1419. [PubMed] [Google Scholar]
  9. Ng W. S., Chau P. Y., Ling J., Echeverria P., Rockhill R., Arnold K. Penicillinase-producing Neisseria gonorrhoeae isolates from different localities in south east Asia. Susceptibility to 15 antibiotics. Br J Vener Dis. 1983 Aug;59(4):232–236. doi: 10.1136/sti.59.4.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Panikabutra K., Ariyarit C., Chitwarakorn A., Saensanoh C., Wongba C. Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea. Genitourin Med. 1985 Apr;61(2):106–108. doi: 10.1136/sti.61.2.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wallin J., Siegel M. S. Pharyngeal neisseria gonorrhoeae: coloniser or pathogen? Br Med J. 1979 Jun 2;1(6176):1462–1463. doi: 10.1136/bmj.1.6176.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wiesner P. J., Tronca E., Bonin P., Pedersen A. H., Holmes K. K. Clinical spectrum of pharyngeal gonococcal infection. N Engl J Med. 1973 Jan 25;288(4):181–185. doi: 10.1056/NEJM197301252880404. [DOI] [PubMed] [Google Scholar]
  13. Worm A. M., Fogh H., Petersen C. S. Gonorédiagnostik og behandlingskontrol. Effekt og omkostninger. Ugeskr Laeger. 1986 Oct 27;148(44):2819–2821. [PubMed] [Google Scholar]
  14. Young H., Bain S. S. Neisserial colonisation of the pharynx. Br J Vener Dis. 1983 Aug;59(4):228–231. doi: 10.1136/sti.59.4.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Zajdowicz T. R., Sanches P. L., Berg S. W., Kerbs S. B., Newquist R. L., Harrison W. O. Comparison of ceftriaxone with cefoxitin in the treatment of penicillin-resistant gonococcal urethritis. Br J Vener Dis. 1983 Jun;59(3):176–178. doi: 10.1136/sti.59.3.176. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES